Presentation is loading. Please wait.

Presentation is loading. Please wait.

Use of Atypical Antipsychotic Drugs by Children and Adolescents in the United States: A Retrospective Cohort Study Lesley H. Curtis, PhD Center for Clinical.

Published byRalph Jacobs Modified over 9 years ago

Similar presentations

Presentation on theme: "Use of Atypical Antipsychotic Drugs by Children and Adolescents in the United States: A Retrospective Cohort Study Lesley H. Curtis, PhD Center for Clinical."— Presentation transcript:

1 Use of Atypical Antipsychotic Drugs by Children and Adolescents in the United States: A Retrospective Cohort Study Lesley H. Curtis, PhD Center for Clinical and Genetic Economics Duke Clinical Research Institute Duke University Medical Center

2 Research Team Lesley H. Curtis Leah E. Masselink Truls Østbye Steve Hutchison Peter E. Dans Alan Wright Ranga R. Krishnan Kevin A. Schulman

3 Funding/Support Supported in part by a Centers for Education and Research on Therapeutics (CERTs) cooperative agreement with the Agency for Healthcare Research and Quality.

4 Background Pediatric use of psychotropic medications has received considerable attention in scientific literature and news media Documented use of CNS stimulants, SSRIs, tricyclic and other antidepressants, and antipsychotics Most studies predate atypical antipsychotics, but there is evidence of increasing use of these drugs in pediatric populations

5 Atypical Antipsychotics FDA-approved atypical antipsychotics for treatment of schizophrenia: –risperidone –olanzapine –quetiapine –clozapine –ziprasidone In adults, atypical antipsychotics are at least as efficacious as traditional antipsychotics and have a lower risk of extrapyramidal side effects

6 Prescriptions for Antipsychotics, 1993-2000 Source: Verispan Source Prescription Audit, 1993-2000

7 Atypical Antipsychotics in Children and Adolescents No atypical antipsychotic drugs are approved for use in pediatric populations Data supporting safety and efficacy of atypical antipsychotics for children and adolescents are limited –9 randomized controlled trials in children aged 10 years and younger –small sample sizes (≤ 120 patients) –short follow-up (≤ 10 weeks)

8 Atypical Antipsychotics in Children and Adolescents Adverse effects (ie, weight gain, sedation, and extrapyramidal symptoms) may be more prevalent and more severe in children and adolescents than in adults

9 Study Objective To examine the use of atypical antipsychotic drugs by children and adolescents in a large national database of prescription drug claims for patients with prescription drug insurance

10 Data Source Outpatient prescription claims database of AdvancePCS –Largest pharmaceutical benefit manager in the United States, covering 30 million lives –More than 98% of claims processed electronically at point of sale

11 Study Population Individual-level claims Subjects aged ≤ 19 years and enrolled continuously throughout 2001 Subjects filed at least 1 claim for any prescription drug in 2001 1171 insurance carriers covering all 50 states, DC, Puerto Rico, and the US Virgin Islands

12 Data Analysis “Annual Prevalence” Number of children and adolescents per 100 000 with at least 1 prescription drug claim for a drug of interest in 2001 Calculated annual prevalence for each atypical antipsychotic drug individually Also calculated annual prevalence for concurrent use of antidepressant drugs

13 Data Analysis (cont.) Stratified by gender to explore gender differences in the use of atypical antipsychotics Used chi-square or Fisher exact tests to test for differences in proportions and prevalence rates

14 Subject Characteristics Characteristic Study Population (n = 6 213 824) MaleFemale All3 187 077 (51.2)3 029 747 (48.8) Age, y 0 to 4722 971 (22.7)683 352 (22.6) 5 to 9826 626 (26.0)784 492 (25.9) 10 to 14842 486 (26.5)802 853 (26.5) 15 to 19791 994 (24.9)759 050 (25.1)

15 Annual Prevalence of the Use of Atypical Antipsychotics Characteristic Subjects with ≥ 1 Claim for an Atypical Antipsychotic (n = 16 599) MaleFemale n (%) Annual Prevalence*n (%) Annual Prevalence* All11 728 (70.7)368.34871 (29.3)160.8† Age, y† 0 to 4223 (1.9)30.848 (1.0)7.0 5 to 92798 (23.9)338.5761 (15.6)97.0 10 to 145007 (42.7)594.31853 (38.0)230.8 15 to 193700 (31.5)467.22209 (45.4)291.0 * Number of subjects per 100 000 with ≥ 1 claim for a drug of interest in 2001. † P <.0001.

16 Prevalence of the Use of Atypical Antipsychotics by Age and Gender * Number of subjects per 100 000 with ≥ 1 claim for an atypical antipsychotic in 2001.

17 Annual Prevalence of the Use of Atypical Antipsychotics by Drug Characteristic Subjects with ≥ 1 Claim for an Atypical Antipsychotic (n = 16 599) MaleFemale n (%) Annual Prevalence*n (%) Annual Prevalence* All11 728 (70.7)368.34871 (29.3)160.8† Clozapine58 (0.5)1.827 (0.6)0.9† Olanzapine3151 (27.1)99.01369 (28.1)45.2† Quetiapine1849 (16.1)58.11257 (25.8)41.5† Risperidone8121 (69.4)255.12980 (61.2)98.4† Ziprasidone398 (3.5)12.5264 (5.4)8.7† Concurrent use of antidepressant6131 (52.3)192.63236 (66.3)106.8† * Number of subjects per 100 000 with ≥ 1 claim for a drug of interest in 2001. † P <.0001.

18 Limitations Filed claims, not drugs actually taken Does not capture out-of-pocket payments or alternative sources of payment Persons of lower socioeconomic status may be underrepresented Clinical variables not directly available in data set

19 Importance Increasing use of atypical antipsychotics Long-term effects of early and prolonged exposure are unknown; data in pediatric populations are limited Preliminary evidence that side effects may be more common and more severe in children

20 Relevance to Clinical Practice Off-label use of prescription drugs in children and adolescents is common, despite lack of data Primary care physicians may be more likely than pediatric psychopharmacologists to prescribe psychotropic drugs Implications for safety and efficacy of extrapolating from adult dosages and schedules?

21 Relevance to Policy Medicaid provides coverage for drug therapy but limited reimbursement for psychiatric evaluation Incentive to treat behavioral problems using drug therapy?

22 Relevance to Health Services Research Potential for using large PBM databases for postmarketing surveillance of prescription drugs Potential to examine “real-time” use of prescription drugs May also be useful for exploring associations observed in case reports

23 Relevance to Health Services Research However, must move beyond claims data toward understanding the clinical circumstances

Download ppt "Use of Atypical Antipsychotic Drugs by Children and Adolescents in the United States: A Retrospective Cohort Study Lesley H. Curtis, PhD Center for Clinical."

Similar presentations

Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.

Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.
SUTENT  (sunitinib malate) capsules Access Slide Kit.

SUTENT  (sunitinib malate) capsules Access Slide Kit.
Do Health Care Regulation and Physician-Industry Interaction Influence Antibiotic Resistance Rates? The Example of Antimicrobial Prescribing and Dispensing.

Do Health Care Regulation and Physician-Industry Interaction Influence Antibiotic Resistance Rates? The Example of Antimicrobial Prescribing and Dispensing.
OBJECTIVES To examine the prevalence of potentially inappropriate medication use (PIMs) among community-dwelling older adults in a managed care organization.

OBJECTIVES To examine the prevalence of potentially inappropriate medication use (PIMs) among community-dwelling older adults in a managed care organization.
The Antipsychotic Atlas Project - Overview Kennedy, J (PI); S Murphy; S McPherson & M Layton (co-Is) Start date: 9/13End date: 8/15 This research project.

The Antipsychotic Atlas Project - Overview Kennedy, J (PI); S Murphy; S McPherson & M Layton (co-Is) Start date: 9/13End date: 8/15 This research project.
Variation in Antipsychotic Medication Use and Expenditures Across State Medicaid Programs Jacqueline R. Chaudhry.

Variation in Antipsychotic Medication Use and Expenditures Across State Medicaid Programs Jacqueline R. Chaudhry.
Impact of Side Effects of Antipsychotics on Attitude and Adherence to Treatment among Adult Psychiatric Outpatients at Mathari Hospital in Kenya Defense.

Impact of Side Effects of Antipsychotics on Attitude and Adherence to Treatment among Adult Psychiatric Outpatients at Mathari Hospital in Kenya Defense.
Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia? By : s.bruce, PhD et al (Am J Psychiatry.

Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia? By : s.bruce, PhD et al (Am J Psychiatry.
Interpreting Adverse Signals in Diabetes Drug Development Programs Featured Article: Clifford J. Bailey, Ph.D. Diabetes Care Volume 36: 1-9 July, 2013.

Interpreting Adverse Signals in Diabetes Drug Development Programs Featured Article: Clifford J. Bailey, Ph.D. Diabetes Care Volume 36: 1-9 July, 2013.
1 Obesity Treatment in Special Populations Smokers –All smokers, regardless of weight, should quit smoking. –Implement weight gain prevention, treatment.

1 Obesity Treatment in Special Populations Smokers –All smokers, regardless of weight, should quit smoking. –Implement weight gain prevention, treatment.
Postmarketing Risk Assessment of Drug Products Division of Drug Risk Evaluation Office of Drug Safety Center for Drug Evaluation and Research.

Postmarketing Risk Assessment of Drug Products Division of Drug Risk Evaluation Office of Drug Safety Center for Drug Evaluation and Research.
1 Managed Health Care Pricing for Provider Arrangements Presented by Vanessa Olson Seminar on Health and Managed Care October 18, 1999.

1 Managed Health Care Pricing for Provider Arrangements Presented by Vanessa Olson Seminar on Health and Managed Care October 18, 1999.
Dynamics of Care in Society Health Care Economics 1.

Dynamics of Care in Society Health Care Economics 1.
Prevalence of Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States Swapna U. Karkare, MS, Sandipan Bhattacharjee, MS,

Prevalence of Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States Swapna U. Karkare, MS, Sandipan Bhattacharjee, MS,
As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,

As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Trends in the.

Agency for Healthcare Research and Quality Advancing Excellence in Health Care Trends in the.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,

Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.

Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Implementing NICE guidance

Implementing NICE guidance
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.

1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.

Similar presentations

Ads by Google